The HIF‐1 signaling pathway emerged as the most significantly enriched signaling pathway, suggesting that it was the pivotal pathway through which EZP and EYP exerted their therapeutic effects on diabetic nephropathy (Figure 5A). This evidence concerns the gene HIF1A and diabetic kidney disease.